SCM
ABBV icon

Sirios Capital Management’s AbbVie ABBV Stock Holding History

Sirios Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-188,888
Closed -$12.4M – 51
2014
Q4 		$12.4M Sell
188,888
-214,687
-53% -$13.5M 0.45% 42
2014
Q3 		$23.3M Buy
+403,575
New +$22.4M 0.81% 34

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sirios Capital Management's ABBV Position: Q1 2015 in Review

Sirios Capital Management sold out of AbbVie (ABBV) in Q1 2015, closing a stake of 188,888 shares — an estimated $12.4M sold.

Sirios Capital Management first reported a position in ABBV in Q3 2014 and held it in 2 quarters. The position peaked at $23.3M in Q3 2014. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Sirios Capital Management reported no remaining AbbVie position as of Q1 2015 after selling out during the quarter.
  • Sirios Capital Management sold 188,888 AbbVie shares in Q1 2015, an estimated $12.4M.
  • Sirios Capital Management first reported a position in AbbVie in Q3 2014 and held it in 2 quarters.
  • Sirios Capital Management's AbbVie position peaked at $23.3M in Q3 2014.
  • 1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Sirios Capital Management's 13F filing for Q1 2015, filed 15 May 2015.